Vanilloids in pancreatic cancer: potential for chemotherapy and pain management

Abstract

Background: Success of chemotherapy and alleviation of pain are frequently less than optimal in pancreatic cancer patients, leading to increasing interest in new pharmacological substances, such as vanilloids. Our study addressed the question of whether vanilloids influence pancreatic cancer cell growth, and if vanilloids could be used for pain treatment via the vanilloid 1 receptor (VR1) in pancreatic cancer patients. Methods: In vitro, the effect of resiniferatoxin (vanilloid analogue) on apoptosis and cell growth in pancreatic cancer cells-either alone, combined with 5-fluorouracil (5-FU), or combined with gemcitabine-was determined by annexin V staining, FACS analysis, and MTT assay, respectively. VR1 expression was evaluated on RNA and protein level by quantitative polymerase chain reaction and immunohistochemistry in human pancreatic cancer and chronic pancreatitis. Patient characteristicsespecially pain levels-were registered in a prospective database and correlated with VR1 expression. Results: Resiniferatoxin induced apoptosis by targeting mitochondrial respiration and decreased cell growth in pancreatic cancer cells without showing synergistic effects with 5-FU or gemcitabine. Expression of VR1 was significantly upregulated in human pancreatic cancer and chronic pancreatitis. VR1 expression was related to the intensity of pain reported by cancer patients but not to the intensity of pain reported by patients with chronic pancreatitis. Conclusions: Resiniferatoxin induced apoptosis in pancreatic cancer cells indicates that vanilloids may be useful in the treatment of human pancreatic cancer. Furthermore, vanilloid might be a novel and effective treatment option for neurogenic pain in patients with pancreatic cancer.

The G Protein–Coupled Receptor–Transient Receptor Potential Channel Axis: Molecular Insights for Targeting Disorders of Sensation and Inflammation

“…Several lines of evidence support the importance of neurogenic inflammation in the etiology of pancreatitis, including increased pancreatic innervation, elevated neurotransmitter content in pancreatic afferents, and reduction in pancreatitis severity by destruction of primary afferent neurons (Nathan et al, 2002;Hartel et al, 2006;Noble et al, 2006;Schwartz et al, 2013).…”

Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1

“…Capsaicin is one of the major pungent ingredients found in red peppers, which are among the most commonly and frequently used spices in the world (14,15). Due to its analgesic activity, topical application of capsaicin has been used in clinical practice for the treatment of neuropathic pain (16,17). Capsaicin has been revealed to inhibit growth and induce apoptosis in various malignant cell lines (18)(19)(20)(21).…”

Expression and Prognostic Roles of TRPV5 and TRPV6 in Non-Small Cell Lung Cancer after Curative Resection

“…In other reports, the prognostic values of TRPV5 and TRPV6 were also studied (Hartel et al, 2006), and the results remained controversial. In this study, the level of TRPV5 and TRPV6 showed a tendency of being associated with patients' survival.…”